Biologics US 2024: ADC Discovery & Development Conference: A Multi-Pronged Strategy for a Multipartite Molecule: The IP Space For ADC

Jean Ge will speak on a panel titled “A Multi-Pronged Strategy for a Multipartite Molecule: The IP Space For ADC” at the Antibody-Drug Conjugate (ADC) Discovery & Development Conference in conjunction with the Biologics US 2024 program. This panel will discuss developing multi-pronged and coordinated patent strategies to maximize global patent and regulatory exclusivities for ADC drugs, assessing freedom-to-operate and monitoring competitive landscape, and recent ADC litigations.